Evidence map›Paper›PMID 41262633›Full record

ArticleArchivos peruanos de cardiologia y cirugia cardiovascular

Immune checkpoint inhibitor-induced myocarditis: a comprehensive review with clinical case insights.

María José Santa-Ana-Bayona, Camila Ponce-Acosta, Edgar Quispe-Silvestre, Gilberto H Acosta-Gutiérrez, Alfonso González-Trejo, Hugo A Valencia-Hernández, Enrique C Guerra, Pablo O Alarcón-Toxqui, Karina Martínez-Bañagas, Nilda Espinola-Zavaleta

Abstract read
In one paragraph

Article in Archivos peruanos de cardiologia y cirugia cardiovascular. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

María José Santa-Ana-BayonaFacultad Mexicana de Medicina, Universidad La Salle, Ciudad de México, México. Universidad La Salle Facultad Mexicana de Medicina Universidad La Salle Ciudad de México Peru.ORCID https://orcid.org/0009-0008-3476-9711
Camila Ponce-AcostaFacultad Mexicana de Medicina, Universidad La Salle, Ciudad de México, México. Universidad La Salle Facultad Mexicana de Medicina Universidad La Salle Ciudad de México Peru.ORCID https://orcid.org/0009-0006-3090-6681
Edgar Quispe-SilvestreDepartamento de Cardiología, Clínica Ricardo Palma, Lima, Perú. Universidad Ricardo Palma Departamento de Cardiología Clínica Ricardo Palma Lima Peru.ORCID https://orcid.org/0000-0003-4431-1882
Gilberto H Acosta-GutiérrezInstituto de Ciencias Biomédicas, Universidad Autónoma de Ciudad Juárez, Juárez, México Universidad Autónoma de Ciudad Juárez Instituto de Ciencias Biomédicas Universidad Autónoma de Ciudad Juárez Juárez Mexico.ORCID https://orcid.org/0009-0007-0569-7029
Alfonso González-TrejoFacultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, México. Universidad Nacional Autónoma de México Facultad de Medicina Universidad Nacional Autónoma de México Ciudad de México Mexico.ORCID https://orcid.org/0009-0009-8347-9523
Hugo A Valencia-HernándezFacultad de Medicina, Universidad Villa Rica, Veracruz, México. Universidad Villa Rica Facultad de Medicina Universidad Villa Rica Veracruz Mexico.ORCID https://orcid.org/0009-0005-8436-354X
Enrique C GuerraPrograma (PECEM), Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, México. Universidad Nacional Autónoma de México Programa (PECEM) Facultad de Medicina Universidad Nacional Autónoma de México Ciudad de México Mexico.ORCID https://orcid.org/0000-0003-0677-9935
Pablo O Alarcón-ToxquiFacultad de Medicina, Benemérita Universidad Autónoma de Puebla, Puebla, México. Benemérita Universidad Autónoma de Puebla Facultad de Medicina Benemérita Universidad Autónoma de Puebla Puebla Mexico.ORCID https://orcid.org/0009-0000-6973-051X
Karina Martínez-BañagasFacultad de Ciencias de la Salud Valle de las Palmas, Universidad Autónoma de Baja California, Tijuana Baja California, México. Universidad Autónoma de Baja California Facultad de Ciencias de la Salud Valle de las Palmas Universidad Autónoma de Baja California Tijuana Baja California Mexico.ORCID https://orcid.org/0009-0002-2024-0151
Nilda Espinola-ZavaletaDepartamento de Cardiología Nuclear, Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, México. Departamento de Cardiología Nuclear Instituto Nacional de Cardiología Ignacio Chávez Ciudad de México México.ORCID https://orcid.org/0000-0002-4820-1325

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by significantly improving long-term outcomes across multiple malignancies. Despite their benefits, ICIs can lead to immune-related adverse events, including rare but severe cardiovascular toxicity such as myocarditis, which can be life-threatening. This comprehensive review aims to explore and discuss the mechanisms, clinical presentation, diagnostic challenges, and management strategies of ICI-induced myocarditis, emphasizing the need for early detection and timely intervention. As the use of ICIs continues to expand, further research is essential to fully elucidate the underlying mechanisms and optimize therapeutic strategies to mitigate this potentially fatal complication while maintaining the efficacy of cancer therapy.

Indexed as

Cardiac ImagingCardiotoxicityImmune Checkpoint InhibitorsMyocarditis

Identifiers

PMID41262633
PMCPMC12624509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.